Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01760499 · ClinicalTrials.gov registry record · Phase 1
Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study
A Phase 1 study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01760499 is a Phase 1 study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 15 participants.
The verdict
NCT01760499, a Phase 1 study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The main purpose of this study is to find out more about how PV-10 works in melanoma tumors. Researchers also want to find out if there are changes in the body's immune cells (cells that fight infection and illnesses) after PV-10 is given, both inside the melanoma tumors and circulating in the blood.
Interventions
- PROCEDURE Surgery
- DRUG PV-10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-01-24 |
| Est. Completion | 2017-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01760499
The ClinicalTrials.gov registry entry for NCT01760499 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Surgery is the first listed.
NCT01760499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01760499 about?
NCT01760499 is a clinical study titled "Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study". The main purpose of this study is to find out more about how PV-10 works in melanoma tumors. Researchers also want to find out if there are changes in the body's immune cells (cells that fight infection and illnesses) after PV-10 is given, both inside the melanoma tumors and circulating in the blood...
What is the current status of trial NCT01760499?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2013-01-24. Estimated completion is 2017-04.
What interventions are being tested in trial NCT01760499?
The interventions under investigation include: Surgery (PROCEDURE), PV-10 (DRUG).
Who is sponsoring clinical trial NCT01760499?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.